Q4 2025 Holdings
Filed 2026-02-13 | 47 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $216.0M | 5,346,928 | 14.0% |
| Cidara Therapeutics, Inc.(CDTX) | Common | 171757206 | $211.3M | 956,670 | 13.7% |
| Praxis Precision Medicines(PRAX) | Common | 74006W207 | $96.9M | 328,895 | 6.3% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $85.2M | 2,398,993 | 5.5% |
| Trevi Therapeutics Inc(TRVI) | Common | 89532M101 | $63.8M | 5,094,668 | 4.1% |
| Avadel Pharmaceuticals PLC | ADR | G29687103 | $57.8M | 2,684,109 | 3.7% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $51.3M | 9,545,466 | 3.3% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $51.1M | 2,614,960 | 3.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $48.5M | 359,305 | 3.1% |
| DBV Technologies SA(DBVT) | SPONSORED ADS | 23306J309 | $47.2M | 2,461,626 | 3.1% |
| SAB Biotherapeutics Inc(SABS) | Common | 78397T202 | $42.7M | 11,420,000 | 2.8% |
| Soleno Therapeutics Inc(SLNO) | Common | 834203309 | $41.4M | 894,909 | 2.7% |
| Bright Minds Biosciences Inc(DRUG) | Common | 10919W405 | $39.1M | 501,617 | 2.5% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2M | 5,903,000 | 2.5% |
| Geron Corp(GERN) | Common | 374163103 | $35.9M | 27,225,292 | 2.3% |
| Erasca Inc(ERAS) | Common | 29479A108 | $34.5M | 9,273,428 | 2.2% |
| Zenas Biopharma Inc(ZBIO) | Common | 98937L105 | $31.0M | 853,495 | 2.0% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $30.6M | 982,576 | 2.0% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $26.8M | 8,888,888 | 1.7% |
| Camp4 Therapeutics Inc(CAMP) | Common | 13463J101 | $26.0M | 4,246,568 | 1.7% |
| Tango Therapeutics Inc(TNGX) | Common | 87583X109 | $19.1M | 2,154,780 | 1.2% |
| Alto Neuroscience Inc(ANRO) | Common | 02157Q109 | $18.4M | 1,035,551 | 1.2% |
| LB Pharmaceuticals Inc(LBRX) | Common | 50180M108 | $17.8M | 800,000 | 1.2% |
| Minerva Neurosciences Inc(NERV) | Common | 603380205 | $17.4M | 4,322,747 | 1.1% |
| Oric Pharmaceuticals Inc(ORIC) | Common | 68622P109 | $17.3M | 2,118,384 | 1.1% |
| Corvus Pharmaceuticals Holdings(CRVS) | Common | 221015100 | $17.2M | 2,234,566 | 1.1% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $16.8M | 671,843 | 1.1% |
| Pepgen Inc(PEPG) | Common | 713317105 | $15.1M | 2,325,000 | 1.0% |
| Design Therapeutics Inc(DSGN) | Common | 25056L103 | $15.1M | 1,612,903 | 1.0% |
| Dianthus Therapeutics Inc(DNTH) | Common | 252828108 | $14.6M | 353,998 | 0.9% |
| Moonlake Immunotherapeutics(MLTX) | Common | 61559X104 | $13.2M | 1,000,000 | 0.9% |
| Cytomx Therapeutics Inc(CTMX) | Common | 23284F105 | $12.3M | 2,884,615 | 0.8% |
| Unicycive Therapeutics(UNCY) | Common | 90466Y202 | $10.3M | 1,789,916 | 0.7% |
| Eupraxia Pharmaceuticals Inc(EPRX) | Common | 29842P105 | $10.2M | 1,350,000 | 0.7% |
| Abeona Therapeutics, Inc.(ABEO) | Common | 00289Y206 | $9.7M | 1,842,751 | 0.6% |
| Verastem Inc(VSTM) | Common | 92337C203 | $8.5M | 1,106,524 | 0.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $6.7M | 1,105,454 | 0.4% |
| Monopar Therapeutics Inc(MNPR) | Common | 61023L207 | $5.9M | 90,500 | 0.4% |
| Surrozen Inc(SRZN) | Common | 86889P208 | $5.9M | 260,000 | 0.4% |
| Palisade Bio Inc(PALI) | Common | 696389402 | $5.4M | 2,293,578 | 0.3% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $4.9M | 1,650,440 | 0.3% |
| Instil Bio Inc(TIL) | Common | 45783C200 | $3.2M | 292,743 | 0.2% |
| Pasithea Therapeutics Corp(KTTA) | Common | 70261F202 | $2.7M | 2,100,000 | 0.2% |
| Tenax Therapeutics Inc(TENX) | Common | 88032L605 | $2.5M | 208,333 | 0.2% |
| EnGene Holdings Inc(ENGNW) | Warrants | 29286M113 | $843.7K | 285,046 | 0.1% |
| Bolt Therapeutics Inc(BOLT) | Common | 097702203 | $396.0K | 72,414 | 0.0% |
| Precision Biosciences Inc(DTIL) | Common | 74019P207 | $19.4K | 4,675 | 0.0% |